| ProductNum | picture | CAS No. | Name and description | Formula | Quick order | 
|---|---|---|---|---|---|
| CL3145 | 
                         | 
                    257933-82-7 | 
                         Pelitinib (Synonyms: EKB-569; WAY-EKB 569) 98+%  | 
                    C24H23ClFN5O2 | |
| CL1632A | 
                         | 
                    439081-18-2 | 
                         (E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; (S)-阿法替尼) 98+%  | 
                    C24H25ClFN5O3 | |
| CL3050 | 
                         | 
                    133550-30-8 | 
                         AG490 (Synonyms: Tyrphostin AG490; Tyrphostin B42) 98+%  | 
                    C17H14N2O3 | |
| CL2211A | 
                         | 
                    1421373-66-1 | 
                         AZD-9291 mesylate | Osimertinib mesylate | Mereletinib mesylate 98+%  | 
                    C29H37N7O5S | |
| CLA1682 | 
                         | 
                    1826843-81-5 | 
                         Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) 95+%  | 
                    — | |
| CL2895 | 
                         | 
                    937263-43-9 | 
                         Tucatinib | Irbinitinib | ARRY-380 | ONT-380 99+%  | 
                    C26H24N8O2 | |
| CLA1680 | 
                         | 
                    2648260-93-7 | 
                         Becotatug | JMT-101 98+%  | 
                    — | |
| CL2457 | 
                         | 
                    184475-35-2 | 
                         Gefitinib | ZD1839 98+%  | 
                    C22H24ClFN4O3 | |
| CL2423 | 
                         | 
                    183319-69-9 | 
                         Erlotinib Hydrochloride (Synonyms: Erlotinib HCl; CP-358774 hydrochloride; NSC 718781 hydrochloride; OSI-774 hydrochloride; OSI-774 HCl) 98+%  | 
                    C22H23N3O4·HCl | |
| CL2220 | 
                         | 
                    231277-92-2 | 
                         Lapatinib (GW572016; GW2016,Tykerb, Tyverb) 98+%  | 
                    C29H26ClFN4O4S | |
| CLA1578 | 
                         | 
                    2171511-58-1 | 
                         Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372) 95+%  | 
                    — | |
| CLA1500 | 
                         | 
                    1969309-56-5 | 
                         Anti-Human Her2xHer3 (Zenocutuzumab; MCLA-128; PB4188; R040517) 95+%  | 
                    — | |
| CLA1389 | 
                         | 
                    1509928-04-4 | 
                         Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005) 95+%  | 
                    — | |
| CLA1314 | 
                         | 
                    1310460-86-6 | 
                         Modotuximab (Anti-ERBB1 / EGFR / HER1) 95+%  | 
                    — | |
| CLA1304 | 
                         | 
                    959963-46-3 | 
                         Imgatuzumab (Anti-ERBB1 / EGFR / HER1) 95+%  | 
                    — | |
| CLA1303 | 
                         | 
                    1310460-85-5 | 
                         Futuximab 95+%  | 
                    — | |
| CLA1300 | 
                         | 
                    1314238-96-4 | 
                         Duligotuzumab 95+%  | 
                    — | |
| CLA1295 | 
                         | 
                    1262787-83-6 | 
                         Patritumab (Anti-ERBB3 / HER3) 95+%  | 
                    — | |
| CLA1240 | 
                         | 
                    725735-28-4 | 
                         Intetumumab 95+%  | 
                    — | |
| CLA1221 | 
                         | 
                    906805-06-9 | 
                         Necitumumab (anti-EGFR) 95+%  | 
                    — | |